Compare DHX & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHX | MXCT |
|---|---|---|
| Founded | 1991 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.3M | 136.0M |
| IPO Year | 2007 | 2021 |
| Metric | DHX | MXCT |
|---|---|---|
| Price | $3.88 | $1.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $6.25 | $5.50 |
| AVG Volume (30 Days) | 143.8K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $127,826,000.00 | $33,026,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.52 | $18.50 |
| P/E Ratio | $98.50 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.44 | $0.64 |
| 52 Week High | $4.20 | $2.37 |
| Indicator | DHX | MXCT |
|---|---|---|
| Relative Strength Index (RSI) | 58.18 | 60.92 |
| Support Level | $3.39 | $0.77 |
| Resistance Level | $4.00 | $1.33 |
| Average True Range (ATR) | 0.28 | 0.07 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 57.97 | 60.57 |
DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.